Diary - News All news Data Advancing the Clinical Utility of ImmunID’s ImmunTraCkeR®

Data Advancing the Clinical Utility of ImmunID’s ImmunTraCkeR®

ImmunID today announced the publication of a short report in the Journal for ImmunoTherapy of Cancer (JITC) showing that the analysis of peripheral T cell receptor diversity using the company’s ImmunTraCkeR® assay is associated with clinical outcomes following Ipilimumab treatment in metastatic melanoma.

Read the press release

Headlines

Our members

Adocia obtains additional financial resources to accelerate its growth

October 14^th, 2019

Inovotion is once again working with the NC3Rs’ CRACK IT Solutions technology partnering programme to showcase our technology

September 18^th, 2019

Poxel Initiates Phase 1b Multiple Ascending Dose (MAD) Trial for NASH Drug Candidate, PXL065

September 17^th, 2019

All news

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree